Endothelial damage and angiogenesis in hypertensive patients: Relationship to cardiovascular risk factors and risk factor management

American Journal of Hypertension

Volumn 16, Issue 1, 2003, Pages 11-20

  Felmeden, Dirk C ^a   Spencer, Charles G C ^a   Belgore, Funmi M ^a   Blann, Andrew D ^a   Beevers, D Gareth ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Angiogenesis; Endothelial damage; SFlt 1; Vascular endothelial growth factor; Von Willebrand factor

Indexed keywords

CHOLESTEROL; PROTEIN; PROTEIN SFLT 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VON WILLEBRAND FACTOR;

ADULT; ANGIOGENESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; RISK FACTORS; RISK REDUCTION BEHAVIOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

EID: 0037233310     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03149-7     Document Type: Article

References (31)

1. Blann AD, Lip GYH: The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. Blood Coag & Fibrinolys 1998;9:297-306.
2. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
3. Celermajer DS: Endothelial dysfunction: Does it matter? Is it reversible? J Am Cardiol 1997;30:325-333.
4. Blann AD, Naqvi T, Waite M, McCollum CN: Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993;7:107-111.
5. Hutchins PM, Darnell AE: Observation of a decreased number of small arterioles in spontaneous hypertensive rats. Circ Res 1974;34/35(Suppl 1):161-165.
6. Sullivan JM, Prewitt RL, Josephs JA: Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983;5:844-851.
7. Struijker Boudier HAJ, Le Noble JLML, Messing MWJ, Huijberts MSP, Le Noble FAC, Van Essen H: The microcirculation in hypertension. J Hypertens 1992;10(Suppl 7):147.
8. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Schwartz SM: Angiogenesis in human coronary artery plaques. Am J Pathol 1994:145;883-894.
9. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA: Early expression of angiogenesis factors in acute myocardial ischaemia and infarction. N Engl J Med 2000;342:626-633.
10. Belgore F, Blann AD, Li-Saw-Hee FL, Beevers DG, Lip GYH: Plasma levels of vascular endothelial growth factor and its soluble receptor (sFlt-1) in essential hypertension. Am J Cardiol 2001;87:805-807.
11. Kannel WB, McGee D, Gordon T: A general cardiovascular risk profile; the Framingham Study. Am J Cardiol 1976;38:46-51.
12. Jansson J-H, Nilsson TK, Johnson O: von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991;66:351-355.
13. Thompson SG, Kienast J, Pyke S, Haverkate F, van de Loo JC: Haemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995;332:635-641.
14. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J: Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens 2001;19:1139-1147.
15. Spencer CGC, Beevers DG, Lip GYH: Haemorheological, endothelial and platelet function in subjects with hypertension: Relationship to cardiovascular risk and influence of antihypertensive treatment. J Hum Hypertens 2001;15(Suppl 1):S39.
16. O'Brien E, Petrie J, Littler WA, de Swiet M, Padfield PL, Altman D, Bland M, Coats A, Atkins N: The British Hypertension Society Protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993:11(Suppl 2):S43-S63.
17. Leng GC, Fowkes FG: The Edinburgh Claudication Questionnaire: An improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45:1101-1109.
18. Belgore FM, Blann AD, Lip GYH: Measurement of free and complexed soluble VEGF receptor Fit-1 (sFlt-1) in fluid samples. Clin Science 2001;100:567-575.
19. Short PE, Williams CE, Picken AM, Hill FGH: Factor VIII related antigen: An improved enzyme immunoassay. Med Lab Sciences 1982;39:351-355.
20. Machin D, Campbell M: Statistical Tables for the Design of Clinical Trials. Oxford, Blackwell Scientific, 1987.
21. Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, 1991.
22. Li J, Zhao SP, Li XP, Zhua QC, Gao M, Lu SK: Non-invasive detection of endothelial dysfunction in patients with endothelial dysfunction. Int J Cardiol 1997;19:165-169.
23. Iiyama K, Nagano M, Yo Y, Kamide K Higaki J, Mikami H, Ogihara T: Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J 1996;132:779-782.
24. Anderson KM, Odell PM, Wilson PW, Kannel WB: Cardiovascular disease risk profiles. Am Heart J 1991:121:293-298.
25. Jager A, van Hinsbergh VWM, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects. Arterioscler Thromb Vasc Biol 1999;19:3071-3078.
26. Catto AJ, Carter AM, Barrett JH, Bamford J, Rice PJ, Grant PJ: von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality. Thromb Haemost 1997;77:1104-1108.
27. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Prevention, Detection. Evaluation and Treatment of High Blood Pressure. Arch Int Med 1997;24:2413-2446.
28. Le Noble JL, Tangelder GJ, Slaaf DW, Van Essen H, Reneman RS, Struijker Boudier HAJ: A functional morphometric study of the cremaster muscle microcirculation in young spontaneous hypertensive rats. J Hypertens 1990;8:741-748.
29. Struijker Boudier HAJ, Crijns FRL, Stolte J, Van Essen H: Assessment of the microcirculation in cardiovascular disease. Clin Sci 1996;91:131-139.
30. Le Noble FAC, Stassen FRM, Hacking WJG, Struijker Boudier HAJ: Angiogenesis and hypertension. J Hypertens 1998;16:1563-1572.
31. Lee AJ: The role of rheological and haemostatic factors in hypertension. J Hum Hypertens 1997;11:767-776.